MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.010
-0.040 (-1.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed
MacroGenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 149.5 | 149.96 | 58.75 | 151.94 | 77.45 | Upgrade
|
| Revenue Growth (YoY) | -0.31% | 155.26% | -61.33% | 96.19% | -26.16% | Upgrade
|
| Cost of Revenue | 183.18 | 189.49 | 174.81 | 214.41 | 217.23 | Upgrade
|
| Gross Profit | -33.68 | -39.53 | -116.06 | -62.47 | -139.78 | Upgrade
|
| Selling, General & Admin | 39.16 | 71.05 | 52.19 | 58.95 | 63.01 | Upgrade
|
| Operating Expenses | 39.16 | 71.05 | 52.19 | 58.95 | 63.01 | Upgrade
|
| Operating Income | -72.84 | -110.58 | -168.24 | -121.42 | -202.8 | Upgrade
|
| Interest Expense | -8.51 | -1.12 | -1.43 | - | - | Upgrade
|
| Interest & Investment Income | 6.06 | 9.42 | 9.69 | 1.66 | 0.68 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 150.93 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -75.29 | -102.27 | -9.06 | -119.76 | -202.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 36.25 | - | - | - | Upgrade
|
| Pretax Income | -75.29 | -66.02 | -9.06 | -119.76 | -202.12 | Upgrade
|
| Income Tax Expense | -0.67 | 0.94 | - | - | - | Upgrade
|
| Net Income | -74.62 | -66.97 | -9.06 | -119.76 | -202.12 | Upgrade
|
| Net Income to Common | -74.62 | -66.97 | -9.06 | -119.76 | -202.12 | Upgrade
|
| Shares Outstanding (Basic) | 63 | 63 | 62 | 61 | 60 | Upgrade
|
| Shares Outstanding (Diluted) | 63 | 63 | 62 | 61 | 60 | Upgrade
|
| Shares Change (YoY) | 0.85% | 1.12% | 0.81% | 2.48% | 14.31% | Upgrade
|
| EPS (Basic) | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 | Upgrade
|
| EPS (Diluted) | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 | Upgrade
|
| Free Cash Flow | -82.95 | -72.08 | -79.97 | -90.58 | -150.03 | Upgrade
|
| Free Cash Flow Per Share | -1.31 | -1.15 | -1.29 | -1.47 | -2.50 | Upgrade
|
| Gross Margin | -22.53% | -26.36% | -197.54% | -41.11% | -180.49% | Upgrade
|
| Operating Margin | -48.72% | -73.74% | -286.38% | -79.91% | -261.85% | Upgrade
|
| Profit Margin | -49.91% | -44.66% | -15.42% | -78.82% | -260.97% | Upgrade
|
| Free Cash Flow Margin | -55.49% | -48.07% | -136.12% | -59.62% | -193.72% | Upgrade
|
| EBITDA | -65.67 | -103.04 | -158.6 | -109.55 | -191.54 | Upgrade
|
| EBITDA Margin | -43.93% | -68.71% | -269.96% | -72.10% | -247.31% | Upgrade
|
| D&A For EBITDA | 7.17 | 7.54 | 9.65 | 11.87 | 11.26 | Upgrade
|
| EBIT | -72.84 | -110.58 | -168.24 | -121.42 | -202.8 | Upgrade
|
| EBIT Margin | -48.72% | -73.74% | -286.38% | -79.91% | -261.85% | Upgrade
|
| Revenue as Reported | 149.5 | 149.96 | 58.75 | 151.94 | 77.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.